Projects

Analysis of Risk Factors for Perinatal Asphyxia

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2021 - 2021

Project Lead

Authors

Andreas Chiabi, Walter Dobgima Pisoh, Flavila Tchoupou Tsayim, Moses Samje, Evelin Feuldi, Frida Sunjo, Daniel Armand Kago Tague, Denis Nsame Nforniwe

Project Status

completed

Project Type

Project